Entity Details

Primary name NLRP3_HUMAN
Entity type UniProt
Source Source Link

Details

AccessionQ96P20
EntryNameNLRP3_HUMAN
FullNameNACHT, LRR and PYD domains-containing protein 3
TaxID9606
Evidenceevidence at protein level
Length1036
SequenceStatuscomplete
DateCreated2002-05-02
DateModified2021-06-02

Ontological Relatives

GenesNLRP3

GO terms

Show/Hide Table
GOName
GO:0000139 Golgi membrane
GO:0002523 leukocyte migration involved in inflammatory response
GO:0002674 negative regulation of acute inflammatory response
GO:0002830 positive regulation of type 2 immune response
GO:0005524 ATP binding
GO:0005576 extracellular region
GO:0005634 nucleus
GO:0005737 cytoplasm
GO:0005783 endoplasmic reticulum
GO:0005829 cytosol
GO:0006915 apoptotic process
GO:0006952 defense response
GO:0006954 inflammatory response
GO:0007165 signal transduction
GO:0008134 transcription factor binding
GO:0009595 detection of biotic stimulus
GO:0014070 response to organic cyclic compound
GO:0016579 protein deubiquitination
GO:0032088 negative regulation of NF-kappaB transcription factor activity
GO:0032691 negative regulation of interleukin-1 beta production
GO:0032731 positive regulation of interleukin-1 beta production
GO:0032753 positive regulation of interleukin-4 production
GO:0035590 purinergic nucleotide receptor signaling pathway
GO:0042802 identical protein binding
GO:0042834 peptidoglycan binding
GO:0043280 positive regulation of cysteine-type endopeptidase activity involved in apoptotic process
GO:0043565 sequence-specific DNA binding
GO:0045087 innate immune response
GO:0045471 response to ethanol
GO:0045630 positive regulation of T-helper 2 cell differentiation
GO:0045944 positive regulation of transcription by RNA polymerase II
GO:0050728 negative regulation of inflammatory response
GO:0051092 positive regulation of NF-kappaB transcription factor activity
GO:0071222 cellular response to lipopolysaccharide
GO:0072559 NLRP3 inflammasome complex
GO:1901223 negative regulation of NIK/NF-kappaB signaling
GO:2000553 positive regulation of T-helper 2 cell cytokine production

Subcellular Location

Show/Hide Table
Subcellular Location
Cytoplasm
Endoplasmic reticulum
Golgi apparatus membrane
Inflammasome
Nucleus
Secreted

Domains

Show/Hide Table
DomainNameCategoryType
IPR001611 Leucine-rich repeatRepeatRepeat
IPR004020 DAPIN domainDomainDomain
IPR007111 NACHT nucleoside triphosphataseDomainDomain
IPR011029 Death-like domain superfamilyFamilyHomologous superfamily
IPR027417 P-loop containing nucleoside triphosphate hydrolaseFamilyHomologous superfamily
IPR029495 NACHT-associated domainDomainDomain
IPR032675 Leucine-rich repeat domain superfamilyFamilyHomologous superfamily
IPR041075 NOD2, winged helix domainDomainDomain
IPR041267 NACHT, LRR and PYD domains-containing protein, helical domain HD2DomainDomain

Diseases

Show/Hide Table
Disease IDSourceNameDescription
120100 OMIMFamilial cold autoinflammatory syndrome 1 (FCAS1)A rare autosomal dominant systemic inflammatory disease characterized by recurrent episodes of maculopapular rash associated with arthralgias, myalgias, fever and chills, swelling of the extremities, and conjunctivitis after generalized exposure to cold. Rarely, some patients may also develop late-onset renal amyloidosis. The disease is caused by variants affecting the gene represented in this entry.
191900 OMIMMuckle-Wells syndrome (MWS)A hereditary periodic fever syndrome characterized by fever, chronic recurrent urticaria, arthralgias, progressive sensorineural deafness, and reactive renal amyloidosis. The disease may be severe if generalized reactive amyloidosis occurs. The disease is caused by variants affecting the gene represented in this entry.
148200 OMIMKeratoendothelitis fugax hereditaria (KEFH)An autosomal dominant corneal disease that periodically, and fleetingly, affects the corneal endothelium, stroma, and vision, eventually leading to central corneal stromal opacities in some patients. The disease is characterized by unilateral attacks of ocular pain, pericorneal injection, and photophobia. The acute symptoms vanish in 1-2 days but vision remains blurry for several weeks. The attacks start at the age of 3-12 years and can affect either eye. They generally decrease in frequency and get milder with age. The disease is caused by variants affecting the gene represented in this entry.
607115 OMIMChronic infantile neurologic cutaneous and articular syndrome (CINCA)Rare congenital inflammatory disorder characterized by a triad of neonatal onset of cutaneous symptoms, chronic meningitis, and joint manifestations with recurrent fever and inflammation. The disease is caused by variants affecting the gene represented in this entry.
617772 OMIMDeafness, autosomal dominant, 34, with or without inflammation (DFNA34)A form of sensorineural hearing loss. Sensorineural deafness results from damage to the neural receptors of the inner ear, the nerve pathways to the brain, or the area of the brain that receives sound information. DFNA34 is a postlingual, slowly progressive form with variable severity and variable additional features. Some DFNA34 patients have autoinflammatory manifestations. The disease may be caused by variants affecting the gene represented in this entry.

Interactions

42 interactions

InteractorPartnerSourcesPublicationsLink
NLRP3_HUMANASC_HUMANBioGRID, DIP, HPRD, IntAct, UniProt11786556 15020601 19158675 24630722 28229991 30182366 30653357 32003754 32435622 details
NLRP3_HUMANNLRP3_HUMANIntAct23582325 24630722 details
NLRP3_HUMANKSYK_HUMANIntAct25605870 details
NLRP3_HUMANE2AK2_HUMANDIP22801494 details
NLRP3_HUMANNEK7_HUMANBioGRID, DIP, IntAct26814970 31189953 31762063 31866999 32814053 details
NLRP3_HUMANCALR_HUMANIntAct32814053 details
NLRP3_HUMANODO2_HUMANIntAct32814053 details
NLRP3_HUMANFAF1_HUMANBioGRID17046979 details
NLRP3_HUMANFBXL2_HUMANBioGRID26037928 details
NLRP3_HUMANTRI31_HUMANBioGRID27929086 32323100 32716108 details
NLRP3_HUMANCUL1_HUMANBioGRID30653357 details
NLRP3_HUMANPGM1_HUMANBioGRID30653357 details
NLRP3_HUMANAT1B3_HUMANBioGRID30653357 details
NLRP3_HUMANVDR_HUMANBioGRID31866999 details
NLRP3_HUMANSTABP_HUMANBioGRID32003754 details
NLRP3_HUMANMLP3A_HUMANInnateDB22286270 details
NLRP3_HUMANMAVS_HUMANDIP, IntAct23582325 26494172 details
NLRP3_HUMANCARD8_HUMANHPRD, IntAct15030775 28137891 details
NLRP3_HUMANNLRC4_HUMANBioGRID15107016 details
NLRP3_HUMANSGT1_HUMANBioGRID17435760 details
NLRP3_HUMANHS90A_HUMANBioGRID17435760 details
NLRP3_HUMANDHX33_HUMANBioGRID25172487 details
NLRP3_HUMANULK1_HUMANBioGRID26347139 details
NLRP3_HUMANMEFV_HUMANBioGRID26347139 details
NLRP3_HUMANCHIP_HUMANBioGRID25594175 details
NLRP3_HUMANMARH7_HUMANBioGRID25594175 details
NLRP3_HUMANUBR5_HUMANBioGRID25594175 details
NLRP3_HUMANHDAC6_HUMANBioGRID26471297 details
NLRP3_HUMANUBP50_HUMANBioGRID28094437 details
NLRP3_HUMANARI2_HUMANBioGRID29021376 details
NLRP3_HUMANTXNIP_HUMANBioGRID28326454 30833078 details
NLRP3_HUMANRBX1_HUMANBioGRID30653357 details
NLRP3_HUMANABRX2_HUMANBioGRID30787184 details
NLRP3_HUMANBRCC3_HUMANBioGRID30787184 31866999 details
NLRP3_HUMANCASP8_HUMANBioGRID30182366 details
NLRP3_HUMANP2RY2_HUMANBioGRID31553908 details
NLRP3_HUMANSRC_HUMANBioGRID31553908 details
NLRP3_HUMANMARK4_HUMANBioGRID31167564 details
NLRP3_HUMANSQSTM_HUMANBioGRID32003754 details
NLRP3_HUMANCBLB_HUMANBioGRID31999304 details
NLRP3_HUMANRN125_HUMANBioGRID31999304 details
NLRP3_HUMANIL1B_HUMANBioGRID32597834 details